A complaint by the Federal Trade Commission accuses popular fertility tracking app Premom of illegally sharing private data.
In the complaint, the agency says the app, developed by Easy Healthcare, has been sharing private information with Google and Chinese analytic companies since 2018. Easy Healthcare shared data about users’ reproductive health, pregnancy status and other health-related information that could identify users.
Easy Healthcare also apparently shared identifiable information, like geolocation data, with Chinese analytic companies Jiguang and Umeng. The company did so knowing that the two firms would use the data for their own business purposes or transfer it to another third party. “We will vigorously enforce the Health Breach Notification Rule to defend consumer’s health data from exploitation. Companies collecting this information should be aware that the FTC will not tolerate health privacy abuses,” Director of the FTC’s Bureau of Consumer Protection Sam Levine said.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Former Google CEO says AI at 'center' of technology competition between US and ChinaA former Google CEO said during a Congressional hearing that artificial intelligence is at the “center' of the technology battle between China and the United States.
Leer más »
DOJ Charges Ex-Apple Employee for Stealing Trade SecretsAn ex-Apple software engineer is facing charges for allegedly stealing the company’s autonomous systems technology before booking it to China, the Department of Justice announced Tuesday.
Leer más »
China’s Envoy: China to resume imports of Australian timberChina’s ambassador to Australia, Xiao Qian, said that China is on track to resume imports of Australian timber from Thursday and that talks are underw
Leer más »
Vietnam rebukes China, Philippines over South China Sea conductVietnam on Thursday criticised recent conduct by a Chinese research ship and the Philippine coast guard in the South China Sea, accusing its neighbours of separate actions that were violating its sovereign rights.
Leer más »
FTC’s Amgen Activism Will Spare Smaller BiotechsHeard on the Street: The FTC’s effort to block Amgen’s acquisition of Horizon Therapeutics is putting a damper on the recent biotech stocks rally
Leer más »
FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon TherapeuticsThe FTC filed a lawsuit in federal court seeking an injunction that would prevent the deal from closing.
Leer más »